// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis
Many of the drug ingredients used in generic medicines around the world are produced in China, an